← Back to Patent Explorer
US4150145A Expired / Lapsed US ⏱️ 0.0 years remaining

N-alkylated derivatives of thienamycin sulfoxide and sulfone

Assignee: Merck and Co Inc
•
Filing: 1977-09-15
•
Granted: 1979-04-17
•
Expires: 1997-09-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are N-alkylated derivatives of thienamycin sulfoxide (I, n=1) and sulfone (I, n=2): <IMAGE> I wherein n=1 or 2; and R5, R6, and R7 are, inter alia, hydrogen or alkyl. Such compounds the their pharmaceutically acceptable O- and carboxyl- derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such derivatives, pharmaceutical compositions comprising such derivatives and methods of treatment comprising administering such derivatives and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Burton G. Christensen
  • 👤 Raymond A. Firestone
  • 👤 William J. Leanza

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 12:11
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/10; C07D477/12; C07D477/16; C07D477/20

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 111 words
A compound selected from the group consisting of thienamycin sulfoxides and sulfones having the formulae: ##STR108## wherein: n=1 or 2; A is selected from the group consisting of halo, phosphate and sulfate; R 4 is selected from the group consisting of: hydrogen, sulfo, phosphono, carbamoyl, methylsulfonyl, sulfamoyl, dimethylsulfamoyl, N-methylcarbamoyl, bromoacetyl, hydroxyacetyl, aminoacetyl, dimethylaminoacetyl, trimethylammoniumacetyl, amidinoacetyl, guanidinoacetyl, methoxyacetyl, guanylacetyl, guanylthioacetyl, phosphamoyl, phosphonothioyl, thiocarbamoyl, methoxymethyl, hydroxyethyl, methoxyethyl, dimethylaminomethyl, dimethylaminoethyl, methylthiomethyl, amidinomethyl, and guanidinoethyl; R is hydrogen, ##STR109## R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen (not all of R 5 , R 6 , and R 7 are hydrogen at the same time), ##STR110##
Claim 2
Dependent Claim 111 words
A compound selected from the group consisting of thienamycin sulfoxides and sulfones having the formulae: ##STR108## wherein: n=1 or 2; A is selected from the group consisting of halo, phosphate and sulfate; R 4 is selected from the group consisting of: hydrogen, sulfo, phosphono, carbamoyl, methylsulfonyl, sulfamoyl, dimethylsulfamoyl, N-methylcarbamoyl, bromoacetyl, hydroxyacetyl, aminoacetyl, dimethylaminoacetyl, trimethylammoniumacetyl, amidinoacetyl, guanidinoacetyl, methoxyacetyl, guanylacetyl, guanylthioacetyl, phosphamoyl, phosphonothioyl, thiocarbamoyl, methoxymethyl, hydroxyethyl, methoxyethyl, dimethylaminomethyl, dimethylaminoethyl, methylthiomethyl, amidinomethyl, and guanidinoethyl; R is hydrogen, ##STR109## R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen (not all of R 5 , R 6 , and R 7 are hydrogen at the same time), ##STR110##
Claim 3
Dependent Claim 24 words
A compound according to claim 1 wherein R 5 , R 6 and R 7 are hydrogen or lower alkyl having 1-6 carbon atoms.
Claim 4
Dependent Claim 10 words
A compound according to claim 2 having the structure: ##STR111##
Claim 5
Dependent Claim 10 words
A compound according to claim 2 having the structure: ##STR112##
Claim 6
Dependent Claim 10 words
A compound according to claim 2 having the structure: ##STR113##
Claim 7
Dependent Claim 23 words
An antibiotic pharmaceutical composition consisting essentially of a therapeutically effective amount of a compound according to claim 1 and a pharmaceutical carrier therefor.
Claim 8
Dependent Claim 27 words
An antibiotic pharmaceutical composition consisting essentially of, in unitary dosage form, a therapeutically effective amount of a compound according to claim 1 and a pharmaceutical carrier therefor.

References Cited (Backward Citations)

US4000129A Cited
US3862181A Cited
US4022773A Cited
US3950357A Cited
US4000161A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-04-16 1982-10-16 1983-04-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-04-16 1986-10-16 1987-04-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-04-16 1990-10-16 1991-04-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag